Publikationen von Emons, G.

Huber, D., Seitz, S., Kast, K., Emons, G. und Ortmann, Olaf (2021) Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review. Journal of Cancer Research and Clinical Oncology 147, S. 2035-2045.

Ortmann, Olaf, Huber, D., Seitz, S., Kast, K. und Emons, G. (2020) Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review. Archives of Gynecology and Obstetrics 302, S. 715-720.

Huber, D., Seitz, S., Kast, K., Emons, G. und Ortmann, Olaf (2020) Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review. Archives of Gynecology and Obstetrics 301, S. 875-884. Volltext nicht vorhanden.

Kast, K., Rhiem, K., Wappenschmidt, B., Hahnen, E., Hauke, J., Bluemcke, B., Zarghooni, V., Herold, N., Ditsch, N., Kiechle, M., Braun, M., Fischer, C., Dikow, N., Schott, S. , Rahner, N., Niederacher, D., Fehm, T., Gehrig, A., Mueller-Reible, C., Arnold, N. , Maass, N., Borck, G., de Gregorio, N., Scholz, C., Auber, B., Varon-Manteeva, R., Speiser, D., Horvath, J., Lichey, N., Wimberger, P., Stark, S., Faust, U., Weber, Bernhard H. F. , Emons, G., Zachariae, S., Meindl, A., Schmutzler, R. K., Engel, C. und German Consortium for Hereditary Breast and Ovarian Cancer, (GC-HBOC) (2016) Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. Journal of Medical Genetics 53 (7), S. 465-471. Volltext nicht vorhanden.